Physician profile
Adnan Sadiq
NPI 1063463826
$1,186.93
in general payments reported to CMS, 2019-2025
14 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $137 · 2021: $261 · 2022: $89.47 · 2023: $249 · 2024: $55.77 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $420.85 | 2019-2022 | |
| Medtronic, INC. | $172.73 | 2023 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $163.29 | 2024-2025 | Pascal |
| Regeneron Healthcare Solutions, INC. | $111.48 | 2021 | |
| Abbott Laboratories | $69.89 | 2020-2022 | |
| Lantheus Medical Imaging, INC. | $48.04 | 2019-2023 | Definity |
| Irhythm Technologies, INC. | $40.49 | 2022 | |
| Cardiva Medical, INC. | $26.78 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Amgen INC. | $25.59 | 2023 | |
| Pfizer INC. | $24.15 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $23.35 | 2019 | |
| Daiichi Sankyo INC. | $23.19 | 2019 | |
| Cook Medical LLC | $23.02 | 2025 | Zenith Alpha |
| Siemens Medical Solutions USA, INC. | $14.08 | 2025 | Acuson Maple Diagnostic Ultrasound System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adnan Sadiq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.